Virtuix Holdings Inc. (VTIX) AI Stock Summary

Snapshot

Virtuix is a tiny VR hardware developer trying to commercialize its omni-directional treadmill while facing a serious cash crunch. Revenue grew 18% year-over-year to $4.3M in FY 2025 and gross margin improved to 25%, showing the product is generating more cash per unit than before. However, the business is deeply unprofitable with a $16.8M net loss driven by high interest expenses and operating costs. The company holds only $1.1M in cash against $9.3M of debt, and auditors have formally warned that the company may not be able to continue operating. With a cash runway of roughly seven months, the financial structure is strained.

What's Happening Right Now

• Tue 7th Jul '26 · Partnership: Virtuix signed a strategic partnership with Sirica Therapeutics to deploy Omni One systems for AI-driven autism therapy.
• Tue 30th Jun '26 · Financing: Virtuix amended warrants held by Streeterville Capital, lowering the exercise price to $3.00 per share from $4.00.
• Thu 25th Jun '26 · Financial Filing: Auditors raised substantial doubt about the company's ability to continue as a going concern due to recurring losses and capital deficiency.
• Tue 23rd Jun '26 · Product Launch: Virtuix launched the Omni One for Quest, a treadmill compatible with Meta Quest 2 and 3 headsets, certified under the Made for Meta program.
• Thu 7th May '26 · Contract Win: The company was selected as the lead integrator for a U.S. Marine Corps virtual reality infantry training system using four Omni One treadmills.

Ownership

Institutions hold 0.0%, insiders hold 26.4%.

Bottom Line

Virtuix is a speculative turnaround play with major operational momentum but a terrifying balance sheet. The Meta launch and defense contracts are positive steps for the business, but they must deliver cash fast. The going-concern warning and sub-eight-month cash runway make this a survival story rather than a standard growth investment.